Results 101 to 110 of about 14,764,853 (302)
Qiang Tan,* Yang Gao,* Xiaoyan Lv, Yan Jiao, Jian Lian, Xianbin Ding Institute of Chronic and Non‑communicable Disease Control and Prevention, Chongqing Center for Disease Control and Prevention, Chongqing, 400042, People’s Republic of ...
Tan Q +5 more
doaj
Stakeholder perceptions of current practices and challenges in priority setting for non-communicable disease control in Kenya: a qualitative study. [PDF]
Wanjau MN +3 more
europepmc +1 more source
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers +19 more
wiley +1 more source
CDC activities, 1950-1951. [PDF]
The Communicable Disease Center is a component of the U. S. Public Health Service charged with the responsibility of assisting States, when requested, in the diagnosis, prevention, and control of communicable diseases.
core
Intracerebral hemorrhage (ICH) incidence is poorly documented in Asia, where it is highest globally. We examined ICH incidence in Shandong Province, East China, using a population-based stroke surveillance system established in 2012, aiming to inform ICH
Bingyin Zhang +7 more
doaj +1 more source
T1 Over Squared Proton Density Ratio to Characterize Multiple Sclerosis Lesions
ABSTRACT Objective Differentiating remyelinated from demyelinated lesions in MS remains challenging without histological confirmation. This study introduces the T1‐to‐PD2 ratio (TPR) imaging approach and evaluates its ability to characterize MS lesions alongside other quantitative MRI (qMRI) metrics. Methods Thirty individuals with MS (mean age: 47.5 ±
Sarah J. Wright +10 more
wiley +1 more source
Toolkit for Integrated Serosurveillance of Communicable Diseases in the Americas [PDF]
This publication was supported by the Cooperative Agreement Number, 6 NU66GH002171, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of
core
Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies
ABSTRACT Diabetes‐associated cognitive impairment (DACI) is a common yet underrecognized condition, manifesting along a spectrum from mild cognitive impairment to dementia. DACI encompasses patients who develop vascular dementia (VaD) or Alzheimer's disease (AD) with diabetes as a risk factor; however, in certain patients, particularly those lacking ...
Osman Corbali +4 more
wiley +1 more source
ABSTRACT Objective Progression independent of relapse activity is a major determinant of long‐term disability in multiple sclerosis, but its immunopathologic basis remains incompletely understood. We investigated whether relapse‐independent progression in radiologically stable relapsing–remitting multiple sclerosis is associated with distinct ...
Antonio Bruno +19 more
wiley +1 more source
Background A series of mobility and concerns about falling measurement instruments are recommended by guidelines for fall prevention in older adults for fall risk assessment.
Jingjing Lin +5 more
doaj +1 more source

